"Avec ses activités de chirurgie générale et spécialisée, son service d’urgences 24h/24 et son département d’imagerie médicale hautement développé, l’Hôpital privé Jacques Cartier, établissement du groupe Ramsay Santé, est aujourd’hui une référence du Grand Sud parisien. De plus, son pôle d’excellence en cardiologie et chirurgie cardiaque adulte et pédiatrique est reconnu tant en France qu’à l’étranger, grâce à la renommée des praticiens et à la qualité des infrastructures disponibles au sein de l’Hôpital privé Jacques Cartier."

During the past decade, Hôpital Privé Jacques Cartier conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 9 clinical trials were completed, i.e. on average, 18.8% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 5 clinical trials were completed. i.e. 22.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Privé Jacques Cartier" #1 sponsor was "Edwards Lifesciences" with 4 trials, followed by "European Cardiovascular Research Center" with 4 trials sponsored, "Ceric Sàrl" with 3 trials sponsored, "MicroPort CRM" with 3 trials sponsored and "Abbott Medical Devices" with 3 trials sponsored. Other sponsors include 50 different institutions and companies that sponsored additional 49 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Privé Jacques Cartier" #1 collaborator was "European Cardiovascular Research Center" with 3 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Allies in Cardiovascular Trials Initiatives and Organized" with 1 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator and "Assistance Publique Hopitaux De Marseille" with 1 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Privé Jacques Cartier" are "Coronary Artery Disease" (15 trials), "Acute Coronary Syndrome" (5 trials), "Aortic Valve Stenosis" (5 trials), "Atrial Fibrillation" (5 trials) and "Severe Aortic Stenosis" (4 trials). Many other conditions were trialed in "Hôpital Privé Jacques Cartier" in a lesser frequency.

Most popular intervention types in "Hôpital Privé Jacques Cartier" are "Device" (44 trials), "Other" (9 trials), "Drug" (8 trials), "Procedure" (6 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Bivalirudin" (2 trials), "Calculation of early prognosis score" (2 trials), "(BMS/DES)" (1 trials) and "1 Stent" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Privé Jacques Cartier" are 70 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hôpital Privé Jacques Cartier". undefined are not yet recruiting, 11 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in Hôpital Privé Jacques Cartier, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Privé Jacques Cartier, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 27 trials that are defined as “Not Applicable".